Skip to main content
    K

    Kewaunee Scientific Corporation (KEQU)

    Official site

    CONSUMER CYCLICAL • FURNISHINGS, FIXTURES & APPLIANCES • NASDAQ

    $35.06
    -0.64 (-1.79%)

    Market Cap: $103.36M

    Last updated: Nov 17, 2026 at 3:04 AM ET

    Kewaunee Scientific Corporation (KEQU) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Kewaunee Scientific (KEQU) trades at 12.3x trailing earnings and 0.4x sales. Its P/S of 0.4x is in line with its 5-year median. Its forward P/E is 7.7x. The median P/E across 7 similar companies is 11.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 59.7% higher over the next year. Its free cash flow yield is 10.8%.

    MultipleValue
    P/E (trailing)12.3x
    Forward P/E7.7x
    Price to sales0.4x
    Price to book1.3x
    EV/EBITDA4.9x
    Price to FCF9.3x
    EV/FCF10.3x
    PEGN/A
    FCF yield10.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is in line and its P/B is 7.1% below 1.4x.

    MultipleCurrent5-year median10-year median
    P/S0.4x0.4x0.4x
    P/B1.3x1.5x1.4x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 6 of the 10 year ends shown that have a P/E, its P/E ranged from 7.5x in 2025 to 17.3x in 2017. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$37.417.5x0.4x1.5x
    2024$61.879.8x0.9x3.0x
    2023$29.0712.2x0.4x2.0x
    2022$15.95N/A0.2x1.3x
    2021$12.70N/A0.2x1.0x
    2020$12.50N/A0.2x0.9x
    2019$13.45N/A0.3x0.8x
    2018$33.2414.8x0.6x1.9x
    2017$28.9717.3x0.6x1.8x
    2016$24.4513.4x0.5x1.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About KEQU

    What is KEQU's forward P/E ratio?

    Kewaunee Scientific has a forward P/E ratio of 7.7x.

    Is KEQU stock overvalued?

    GNG's valuation label for KEQU is Fairly valued. Its P/E of 12.3x compares with a median of 11.9x across 7 similar companies.

    What is KEQU's price to sales ratio?

    Kewaunee Scientific has a price to sales ratio of 0.4x.